News About: Pharm. Industry
Alteogen’s ‘similarity’ for Eylea biosimilar with the original medicine
Alteogen(CEO Soon-Jae Park), an antibody biosimilar company, announced the company has secured ‘similarity’ for the Eylea biosimilar(ALT-L9) with the original medicine at a U.S. nonclinical trial and ended it without ...
Pharma industry having a hard time due to tyranny of CSOs
It was told pharmaceutical companies are reportedly having a hard time from the tyranny of some CSOs(Contract Sales Organizations).
According to the pharmaceutical industry, the number of CSOs selling medicines on be...
Korean pharmas start to pioneer ‘Blue Ocean’ CIS countries
Korean pharmaceutical companies have shown interests in the Korea Pharmaceutical & Bio-Pharma Association’s(KPBMA) plan to pioneer new foreign markets. The industry is paying attention to the result of their visit to ...
BioKorea & ICCK sign agreement for Korea-India biotech industries
The Korea Biotechnology Industry Organization(President Jung-Sun Seo, KoreaBio) announced on the 15th the association signed a agreement for the Korea-India biotech industrial cooperation with the Indian Chamber of Co...
Excellent efficacy of Chong Kun Dang’s ‘Duvie’ published in international journal
Chong Kun Dang(CEO Young-Joo Kim) announced on the 12th that a study result which structurally revealed strong antidiabetic efficacy and little incidence of adverse drug reactions with a new diabetes therapy ‘Duvie(ge...
Celltrion Chairman Jung-Jin Seo shows growth vision at JP Morgan Conference
Celltrion Chairman Jung-Jin Seo unprecedentedly stepped on the platform for the Celltrion presentation at JP Morgan Healthcare Conference which started at 9am on the 10th.
“While continuing in developing pipelines wh...
Dong-A ST concludes co-development agreement of immunotherapy with AstraZeneca
Dong-A ST(CEO/Vice President Soo-Hyun Kang) announced on the 11th that the company signed a co-development agreement of innovative immunotherapies with AstraZeneca, an English biotech company, at JP Morgan Healthcare ...
Testimony for Novartis’ rebates from former employee of specialized newspaper company
As a former employee from a specialized newspaper company came forward as a witness in regards to the Novartis rebate case, an examination of a witness was held about the discussion process between Novartis and specia...
LG Chem presents new drug development strategies at JP Morgan Conference
LG Chem will start to let people know of its biotechnology business, which will become the next-generation growth engine.
When it comes to this, LG Chem, on the 10th(local time), announced the company held a company ...
Self-sufficiency of medicines continuously dropping due to increase of introduced medicines from multinational pharmas
The self-sufficiency of finished drugs manufactured in Korea is reportedly getting smaller and smaller with the larger multinational pharmas’ original medicine percentage.
According to the ‘2017 Ministry of Food and ...
